← Back to search

OUTSET MEDICAL, INC.

OM · NASDAQ

Electromedical and Electrotherapeutic Apparatus Manufacturing

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

ESG Scores

Overall ESG
4.9
Environmental
7.7
Social
4.8
Governance
5.1

Gender Diversity

Female Directors0.5%
Female Executives0.45348837209302323%
CEO GenderFemale